Analyst Ratings for Intersect ENT (XENT)

XENT Rating Summary

XENT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on XENT
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $26.40 (-3.3%) * Over Last 12-Mos
Rating Score: 2.9 / 10   Percentile Rank: 32%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/12/2021 SVB Leerink Richard Newitter Downgrade Market Perform
(Outperform)
28.25
(N/A)
28.01
(27.31)
-2.5% Details
8/10/2021 BTIG Ryan Zimmerman Downgrade Neutral
(Buy)
N/A
(N/A)
27.37
(27.31)
-0.22% Details
Like XENT Ratings? Also take a look at MDT, SN, SNN, FCSC

XENT Ratings News